Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials.

Catani, João Paulo Portela; Riechelmann, Rachel P; Adjemian, Sandy; Strauss, Bryan E

Catani, João Paulo Portela; Riechelmann, Rachel P; Adjemian, Sandy; Strauss, Bryan E.

Afiliación

Catani JPP; a Viral Vector Laboratory, Center for Translational Investigation in Oncology , Cancer Institute of Sao Paulo/LIM 24, University of São Paulo School of Medicine , São Paulo , Brazil.
Riechelmann RP; b Cancer Institute of Sao Paulo , University of São Paulo School of Medicine , São Paulo , Brazil.
Adjemian S; c Laboratory of Cell and Molecular Biology, Departament of Immunology , Biomedical Sciences Institute, University of São Paulo , São Paulo , Brazil.
Strauss BE; a Viral Vector Laboratory, Center for Translational Investigation in Oncology , Cancer Institute of Sao Paulo/LIM 24, University of São Paulo School of Medicine , São Paulo , Brazil.

Hum Vaccin Immunother ; 13(5): 1109-1111, 2017 05 04.

Article en En | MEDLINE | ID: mdl-28059608

Asunto(s)

Inmunoterapia/tendencias; Neoplasias/inmunología; Neoplasias/terapia; Ensayos Clínicos como Asunto; ADN/sangre; Genes cdc; Humanos; Inmunoterapia/efectos adversos; Inmunoterapia/métodos; Neoplasias/tratamiento farmacológico; Neoplasias/genética; Medicina de Precisión; Microambiente Tumoral

Palabras clave

cancer; checkpoint blockade; circulating tumor DNA; immunoscore; personalized medicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2017 Tipo del documento: Article País de afiliación: Brasil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google